KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C


Autoria(s): Marangon, Amanda Vansan; Silva, Giovanni Faria; Verdichio de Moraes, Camila Fernanda; Tomasini Grotto, Rejane Maria; Pardini, Maria Ines de Moura Campos; de Pauli, Dayse Sousa; Sell, Ana Maria; Laguila Visentainer, Jeane Eliete; Moliterno, Ricardo Alberto
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/11/2011

Resumo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Natural killer (NK) cells play pivotal roles in immune responses against infection with viruses, such as hepatitis C virus (HCV), and killer cell immunoglobulin-like receptors (KIRs) are related to the activation and inhibition of NK cells. The aim of this study was to investigate the possibility that KIR genes and their human leukocyte antigen (HLA) ligands influence progression to cirrhosis in patients infected with genotype 1 of HCV. A total of 145 Brazilian patients with confirmed chronic hepatitis C grouped from F0 to F4 according to fibrosis progression to cirrhosis were evaluated. Genotyping of KIR and HLA genes was performed by polymerase chain reaction with sequence-specific oligonucleotide probes. The HLA-C2 KIR ligand was more frequent in patients than in healthy controls (74.5% vs 64.3%, p = 0.04, odds ratio (OR) = 1.6, 95% confidence interval (Cl) = 1.03-2.52). Moreover, the HLA-C1C2 genotype was more frequent in patients with advanced fibrosis or cirrhosis (F3-F4 group) than in patients in the F0-F2 group (61.6% vs 44.7%, p = 0.06) and in the F4 group compared with the F0-F3 group (65.7% vs 46.7%, p = 0.05, OR = 2.19, 95% CI = 1.01-4.73). NK and KIR ligands may contribute to the development of liver damage in patients chronically infected by HCV. (C) 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier B.V. All rights reserved.

Formato

1074-1078

Identificador

http://dx.doi.org/10.1016/j.humimm.2011.08.017

Human Immunology. New York: Elsevier B.V., v. 72, n. 11, p. 1074-1078, 2011.

0198-8859

http://hdl.handle.net/11449/11466

10.1016/j.humimm.2011.08.017

WOS:000296546100015

Idioma(s)

eng

Publicador

Elsevier B.V.

Relação

Human Immunology

Direitos

closedAccess

Palavras-Chave #NK cells #HLA #KIR #Hepatitis C #Liver fibrosis
Tipo

info:eu-repo/semantics/article